CDEK
← All organizations

IntraBio Inc

For profitContributed to NMEWebsite ↗

Also known as: INTRABIO | IntraBio Inc

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jun 1, 2019

First marketed drug

Sep 24, 2024

First NDA

Sep 24, 2024

Last known activity

Sep 1, 2026

Timeline

2010s

  1. Jun 1, 2015

    IntraBio Inc— Founded

2020s

  1. Sep 24, 2024

    n-acetylleucine— NDA Organization

Drugs by trial phase (1 distinct, 6 trials)

Phase 3 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (6)

Details

Founded
Oxford, GB Jun 1, 2015
First NDA
Sep 24, 2024
Last known activity
Sep 1, 2026

Designations held

  • Orphan drug
  • Fast track
  • Priority review